Pharmaceutical composition comprising an indolylmaleimide derivative

Details for Australian Patent Application No. 2006220056 (hide)

Owner Novartis AG

Inventors Guitard, Patrice; Wolf, Marie-Christine

Agent Davies Collison Cave

Pub. Number AU-B-2006220056

PCT Pub. Number WO2006/092255

Priority 0504203.1 01.03.05 GB

Filing date 27 February 2006

Wipo publication date 8 September 2006

Acceptance publication date 10 December 2009

International Classifications

A61K 31/404 (2006.01)

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/092255 Priority application(s): WO2006/092255

10 December 2009 Application Accepted

  Published as AU-B-2006220056

8 April 2010 Standard Patent Sealed

22 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220062-Method for evaporating a process stream comprising at least two components

2006220049-Film structure with improved application assistance